Welcome to our dedicated page for Cronos Group Common Share news (Ticker: CRON), a resource for investors and traders seeking the latest updates and insights on Cronos Group Common Share stock.
Cronos Group Inc. (CRON) is a globally diversified and vertically integrated cannabis company with a significant presence across four continents. Headquartered in Toronto, Canada, Cronos operates two wholly-owned Canadian licensed producers, Peace Naturals Project Inc. based in Ontario, and Original BC Ltd. located in British Columbia's Okanagan Valley. These operations are regulated under Health Canada's Access to Cannabis for Medical Purposes Regulations.
Internationally, Cronos has established production and distribution platforms in Israel and Australia, and through an exclusive distribution agreement, has access to over 12,000 pharmacies in Germany. The company focuses on building an iconic brand portfolio and developing disruptive intellectual property, aiming to be a leader in the global cannabis market.
Cronos's medicinal brand, Peace Naturals, and recreational brands, Cove and Spinach, cater to a wide range of consumers. The company exports medical cannabis primarily to Israel, and in the U.S., it holds an option to acquire 10.5% of U.S. multistate operator PharmaCann upon the easing of federal restrictions.
Recently, Cronos has expanded its footprint in Australia, partnering with Vitura to supply high-quality cannabis products. This milestone is significant as the Australian medical cannabis market has grown impressively, with approvals for new patients increasing each year. Additionally, Cronos's Spinach brand has become a top seller in Canada, particularly in the flower and edibles categories.
With a strong emphasis on R&D, Cronos invests in tissue culture and cannabis genetics breeding programs to ensure premium quality. This commitment has enabled the company to produce high-quality products that meet the growing demand in international markets, including the UK and Germany.
The company is also known for its commitment to responsible cannabis research, technology, and product development. With a focus on advancing consumer experiences, Cronos continues to innovate and expand its product offerings globally.
Cronos Group, a global cannabinoid company, announced that Mike Gorenstein, Executive Chairman, will present at the MKM Partners Virtual Conference on December 16, 2020, at 12:30 p.m. EST. The presentation will be accessible via the company's Investors website.
Cronos Group is focused on advancing cannabis research and developing an iconic brand portfolio, including PEACE NATURALS and Spinach.
Cronos Group (NASDAQ: CRON) announced on November 25, 2020, that Mike Gorenstein, the Executive Chairman, will speak at the Cowen 2020 Boston Cannabis Conference on December 2, 2020, at 9:20 a.m. EST. This appearance highlights the company's commitment to advancing the cannabis industry. Cronos Group is focused on building a global portfolio of innovative cannabinoid products, including brands like PEACE NATURALS™, COVE™, and Spinach™.
Cronos Group announced that Executive Chairman Mike Gorenstein will speak at the Jefferies Virtual West Coast Consumer Conference on November 17, 2020, at 1:10 p.m. EST. The event will be accessible via the Investors section of Cronos Group's website.
Cronos Group is a leading global cannabinoid company committed to innovation in cannabis research and product development, with a diverse portfolio that includes brands like PEACE NATURALS™, COVE™, and Spinach™.
Cronos Group has appointed Kurt Schmidt as President and CEO, succeeding Mike Gorenstein, who becomes Executive Chairman. The company launched a new hemp-derived CBD brand, Happy Dance™, in partnership with Kristen Bell. Financially, Cronos reported Q3 2020 net revenue of $11.4 million, a 96% increase year-over-year, driven by growth in the adult-use Canadian market and the Redwood acquisition. However, the gross loss was $1.5 million, and the operating loss rose to $41.2 million, reflecting increased costs from brand development and R&D. The company continues to expand its product portfolio and international presence.
Cronos Group Inc. (NASDAQ: CRON) will host its 2020 Third Quarter Earnings Conference Call on November 5, 2020, at 8:30 a.m. EST. The call will include financial results discussion and a Q&A session with senior management. A live audio webcast will be accessible on the company’s website, and an archive will be available for later viewing. Cronos Group specializes in cannabinoid products, focusing on innovative research and product development across its international brand portfolio, including PEACE NATURALS, COVE, and Spinach.
Cronos Group announced the launch of Happy Dance, a new clean CBD skincare brand co-founded by actress Kristen Bell, on October 14, 2020. The collection includes three products: Whipped Body Butter, Head-to-Toe Coconut Melt, and Stress Away Bath Bomb, all featuring high-quality CBD from full-spectrum hemp extract. Each product undergoes thorough third-party testing and is vegan and cruelty-free. A portion of profits will support the A New Way of Life Re-Entry Project, benefiting women rebuilding their lives after prison.
Cronos Group Inc. has launched its medical brand PEACE NATURALS™ in Israeli pharmacies through Cronos Israel. The cultivation and production occur at their facility in Kibbutz Gan Shmuel, which complies with local certifications. The brand, established in Canada in 2013, aims to provide high-quality products, importing dried flower and plant cuttings from Canada. With a growing medical cannabis market in Israel, Cronos sees significant opportunities for expansion. The company emphasizes its commitment to high standards and improving patient access to medical cannabis.
Cronos Group, a global cannabinoid company, announced that its Executive Chairman, Mike Gorenstein, will speak at the CIBC 19th Annual Eastern Institutional Investor Conference on September 17, 2020, at 2:40 p.m. EDT. The conference will be accessible via a webcast on the Company's investor website. Cronos Group is focused on advancing cannabis research and developing an iconic brand portfolio, including wellness and adult-use brands. Their portfolio includes PEACE NATURALS™, COVE™, Spinach™, Lord Jones™, and PEACE+™.
Cronos Group has appointed Kurt Schmidt as President and CEO, effective September 9, 2020. Schmidt brings over 30 years of consumer packaged goods experience, having held key roles at Blue Buffalo and Nestlé. Mike Gorenstein transitions to Executive Chairman after serving as CEO since 2016. Both leaders aim to drive growth and leverage Cronos' strengths in cannabinoid innovation and brand development. The leadership change is expected to enhance company performance and accelerate its mission to create a strong brand portfolio and advanced cannabis research.
FAQ
What is the current stock price of Cronos Group Common Share (CRON)?
What is the market cap of Cronos Group Common Share (CRON)?
What does Cronos Group Inc. do?
Where is Cronos Group headquartered?
Which brands does Cronos Group own?
What are Cronos Group's international operations?
What recent achievement has Cronos made in Australia?
What is the significance of the Spinach brand for Cronos?
Does Cronos export medical cannabis to other countries?
What research and development efforts is Cronos involved in?
What is Cronos's goal in the cannabis market?
What option does Cronos hold in the United States?
